1.Merck.Merck Receives Fast Track Designation from the U.S. FDA for MK-2060, an Investigational Anticoagulant Therapy. Merck News Relese. Link:https://www.merck.com/news/merck-receives-fast-track-designation-from-the-u-s-fda...
1.Merck.MerckReceives Fast Track Designation from the U.S. FDA for MK-2060, anInvestigational Anticoagulant Therapy. Merck News Relese. Link:https://www.merck.com/news/merck-receives-fast-track-designation-from-the-u-s-fda-for-mk-2060-an-investigational-anticoagulant-therapy/ 2.GlobalStudy of...